Advertisement
Screener

SCYNEXIS, Inc. (SCYX) License and Services Revenue (Deprecated 2018-01-31)

1.5 / 5 stars · 27/92 Roast Me

SCYNEXIS, Inc. License and Services Revenue (Deprecated 2018-01-31)

SCYNEXIS, Inc. (SCYX) reported License and Services Revenue (Deprecated 2018-01-31) of $100.00 thousand for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-08.

Discontinued › Income Statement › Other Income

us-gaap:LicenseAndServicesRevenue · last filed 2018-05-08

  • SCYNEXIS, Inc. license and services revenue (deprecated 2018-01-31) for the quarter ending 2018-03-31 was $100.00K, a 0.00% change year-over-year.
  • SCYNEXIS, Inc. license and services revenue (deprecated 2018-01-31) for the quarter ending 2017-12-31 was $100.00K, a 6.54% decline year-over-year.
  • SCYNEXIS, Inc. license and services revenue (deprecated 2018-01-31) for the quarter ending 2017-09-30 was $100.00K, a 56.25% increase year-over-year.
  • SCYNEXIS, Inc. license and services revenue (deprecated 2018-01-31) for the quarter ending 2017-06-30 was $100.00K, a 56.25% increase year-over-year.
  • SCYNEXIS, Inc. license and services revenue (deprecated 2018-01-31) for fiscal 2017 was $300.00K, a 0.00% change from fiscal 2016.
  • SCYNEXIS, Inc. license and services revenue (deprecated 2018-01-31) for fiscal 2016 was $300.00K, a 16.73% increase from fiscal 2015.
  • SCYNEXIS, Inc. license and services revenue (deprecated 2018-01-31) for fiscal 2015 was $257.00K, a 0.39% increase from fiscal 2014.
  • SCYNEXIS, Inc. license and services revenue (deprecated 2018-01-31) for fiscal 2014 was $256.00K.
Period endLicense and Services Revenue (Deprecated 2018-01-31) 3 monthLicense and Services Revenue (Deprecated 2018-01-31) 3 month as first filedLicense and Services Revenue (Deprecated 2018-01-31) 6 monthLicense and Services Revenue (Deprecated 2018-01-31) 6 month as first filedLicense and Services Revenue (Deprecated 2018-01-31) 9 monthLicense and Services Revenue (Deprecated 2018-01-31) 9 month as first filedLicense and Services Revenue (Deprecated 2018-01-31) 12 monthLicense and Services Revenue (Deprecated 2018-01-31) 12 month as first filed
2018-03-31$100.00K
10-Q · filed 2018-05-08
$200.00K
derived: sum of 2 quarters · filed 2018-05-08
$300.00K
derived: sum of 3 quarters · filed 2018-05-08
$400.00K
derived: sum of 4 quarters · filed 2018-05-08
2017-12-31$100.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-13
$200.00K
derived: sum of 2 quarters · filed 2018-03-13
$300.00K
derived: sum of 3 quarters · filed 2018-03-13
$300.00K
10-K · filed 2018-03-13
2017-09-30$100.00K
10-Q · filed 2017-11-07
$200.00K
derived: sum of 2 quarters · filed 2017-11-07
$200.00K
10-Q · filed 2017-11-07
$407.00K
derived: sum of 4 quarters · filed 2018-05-08
2017-06-30$100.00K
10-Q · filed 2017-08-08
$100.00K
10-Q · filed 2017-08-08
$307.00K
derived: sum of 3 quarters · filed 2018-05-08
$371.00K
derived: sum of 4 quarters · filed 2018-05-08
2017-03-31$100.00K
10-Q · filed 2018-05-08
$207.00K
derived: sum of 2 quarters · filed 2018-05-08
$271.00K
derived: sum of 3 quarters · filed 2018-05-08
$335.00K
derived: sum of 4 quarters · filed 2018-05-08
2016-12-31$107.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-13
$171.00K
derived: sum of 2 quarters · filed 2018-03-13
$235.00K
derived: sum of 3 quarters · filed 2018-03-13
$300.00K
10-K · filed 2018-03-13
$257.00K
10-K · filed 2017-03-13
2016-09-30$64.00K
10-Q · filed 2016-11-07
$128.00K
derived: sum of 2 quarters · filed 2016-11-07
$193.00K
10-Q · filed 2016-11-07
$256.00K
derived: sum of 4 quarters · filed 2017-05-08
2016-06-30$64.00K
10-Q · filed 2016-08-08
$129.00K
10-Q · filed 2016-08-08
$192.00K
derived: sum of 3 quarters · filed 2017-05-08
$256.00K
derived: sum of 4 quarters · filed 2017-05-08
2016-03-31$64.00K
10-Q · filed 2017-05-08
$128.00K
derived: sum of 2 quarters · filed 2017-05-08
$192.00K
derived: sum of 3 quarters · filed 2017-05-08
$256.00K
derived: sum of 4 quarters · filed 2017-05-08
2015-12-31$64.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-13
$128.00K
derived: sum of 2 quarters · filed 2017-03-13
$192.00K
derived: sum of 3 quarters · filed 2017-03-13
$257.00K
10-K · filed 2017-03-13
2015-09-30$64.00K
10-Q · filed 2015-11-13
$128.00K
derived: sum of 2 quarters · filed 2015-11-13
$193.00K
10-Q · filed 2015-11-13
$257.00K
derived: sum of 4 quarters · filed 2017-03-13
2015-06-30$64.00K
10-Q · filed 2015-08-19
$129.00K
10-Q · filed 2015-08-19
$193.00K
derived: sum of 3 quarters · filed 2017-03-13
$254.00K
derived: sum of 4 quarters · filed 2017-03-13
2015-03-31$65.00K
10-Q · filed 2016-05-09
$96.00K
10-Q · filed 2015-05-15
$129.00K
derived: sum of 2 quarters · filed 2017-03-13
$190.00K
derived: sum of 3 quarters · filed 2017-03-13
$255.00K
derived: sum of 4 quarters · filed 2017-03-13
2014-12-31$64.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-13
$125.00K
derived: sum of 2 quarters · filed 2017-03-13
$190.00K
derived: sum of 3 quarters · filed 2017-03-13
$256.00K
10-K · filed 2017-03-13
$378.00K
10-K · filed 2015-03-30
2014-09-30$61.00K
10-Q · filed 2015-11-13
$93.00K
10-Q · filed 2014-11-13
$126.00K
derived: sum of 2 quarters · filed 2015-11-13
$192.00K
10-Q · filed 2015-11-13
$282.00K
10-Q · filed 2014-11-13
$223.00K
derived: sum of 4 quarters · filed 2015-11-13
2014-06-30$65.00K
10-Q · filed 2015-08-19
$96.00K
10-Q · filed 2014-08-13
$130.00K
10-Q · filed 2015-08-19
$189.00K
10-Q · filed 2014-08-13
$162.00K
derived: sum of 3 quarters · filed 2015-10-30
$191.00K
derived: sum of 4 quarters · filed 2015-10-30
2014-03-31$93.00K
8-K · filed 2015-10-30
$97.00K
derived: sum of 2 quarters · filed 2015-10-30
$126.00K
derived: sum of 3 quarters · filed 2015-10-30
$126.00K
derived: sum of 4 quarters · filed 2015-10-30
2013-12-31$4.00K
derived: 8-K 12 month − 10-Q 9 month · filed 2015-10-30
$33.00K
derived: sum of 2 quarters · filed 2015-10-30
$33.00K
derived: sum of 3 quarters · filed 2015-10-30
$95.00K
8-K · filed 2015-10-30
$157.00K
10-K · filed 2015-03-30
2013-09-30$29.00K
10-Q · filed 2014-11-13
$29.00K
derived: sum of 2 quarters · filed 2014-11-13
$91.00K
10-Q · filed 2014-11-13
2013-06-30$0.00
10-Q · filed 2014-08-13
$62.00K
10-Q · filed 2014-08-13
2013-03-31$62.00K
10-Q/A · filed 2014-07-11

Similar stocks

Stock NameCountryMarket CapPE Ratio
PDS Biotechnology Corp (PDSB)United States$0.045B
Grace Therapeutics, Inc. (GRCE)$0.046B-1.83
VERU INC. (VERU)United States$0.043B-3.93
Werewolf Therapeutics, Inc. (HOWL)United States$0.047B
Kairos Pharma, LTD. (KAPA)United States$0.041B
Dogwood Therapeutics, Inc. (DWTX)United States$0.049B
Lite Strategy, Inc. (LITS)United States$0.049B
Incannex Healthcare Inc. (IXHL)$0.040B-22.32
Elicio Therapeutics, Inc. (ELTX)United States$0.049B
Karyopharm Therapeutics Inc. (KPTI)United States$0.039B-0.98